✦ LIBER ✦

Phase II trial of HLA-b7 plasmid dna/lipid (allovectin-7®) immunotherapy in patients with metastatic melanoma

✍ Scribed by J. Gutheil; M. Atkins; P. Schwarzenberger; J. Lutzky; J. Rubin; A. Deisseroth; R. Blum; L. Hutchins; R. Gonzalez

Book ID: 117658440
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 170 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)81075-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical phase II trial of recombinant d

Clinical phase II trial of recombinant dna interferon (interferon alfa 2b) in patients with metastatic malignant melanoma

✍ Thierry Dorval; Thao Palangie; Michel Jouve; Emilio Garcia-Giralt; Lucien Israel 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB 👁 3 views

Patient-Specific Vaccines Derived from A

Patient-Specific Vaccines Derived from Autologous Tumor Cell Lines as Active Specific Immunotherapy: Results of Exploratory Phase I/II Trials in Patients with Metastatic Melanoma

✍ Dillman, Robert O.; DePriest, Carol; DeLeon, Cristina; Barth, Neil M.; Schwartzb 📂 Article 📅 2007 🏛 Mary Ann Liebert 🌐 English ⚖ 319 KB

Phase I Trial of a B7-1 (CD80) Gene Modi

Phase I Trial of a B7-1 (CD80) Gene Modified Autologous Tumor Cell Vaccine in Combination With Systemic Interleukin-2 in Patients With Metastatic Renal Cell Carcinoma

✍ ANTONIA, SCOTT J.; SEIGNE, JOHN; DIAZ, JOSE; MURO-CACHO, CARLOS; EXTERMANN, MART 📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 635 KB

A phase II trial and quality-of-life ana

A phase II trial and quality-of-life analysis of a 5-day regimen of oral 5-fluorouracil bracketed by a 7-day regimen of oral eniluracil in untreated patients with unresectable or metastatic colorectal carcinoma

✍ TimothyJ. Hobday; MichelleR. Mahoney; DanielJ. Sargent; JeffA. Sloan; Richard Go 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 163 KB